TGFB1 and cancer: Labelle et al. demonstrated that direct platelet-tumor cell contacting and platelet-derived TGF-β1 synergistically activate the TGF-β1/Smad pathway in cancer cells, resulting in their EMT transformation and enhanced metastasis [13].